Extracts from Huperzia serrata (HS) function as a cholinesterase inhibitor and a glutamic acid receptor antagonist. We tested a supplement containing HS extracts, curcumin, and others in dementia patients and individuals with mild cognitive impairment (MCI) in an open label study. Most patients with Alzheimer’s disease, dementia with Lewy bodies, and MCI individuals exhibited improvements in cognitive functions, as assessed by the Alzheimer’s Disease Assessment Scale-cognitive subscale Japanese version. The scores were significantly improved at 6–12 weeks compared with baseline scores (p = 0.007) and at 22–28 weeks (p = 0.004). Thus, this supplement may be administered to dementia patients as well as MCI individuals.
XingSH, ZhuCX, ZhangR, AnL (2014) Huperzine A in the treatment of Alzheimer’s disease and vascular dementia: A meta-analysis. Evid Based Complement Alternat Med2014, 363985.
2.
McKeithIG, DicksonDW, LoweJ, EmreM, O’BrienJT, FeldmanH, CummingsJ, DudaJE, LippaC, PerryEK, AarslandD, AraiH, BallardCG, BoeveB, BurnDJ, CostaD, Del SerT, DuboisB, GalaskoD, GauthierS, GoetzCG, Gomez-TortosaE, HallidayG, HansenLA, HardyJ, IwatsuboT, KalariaRN, KauferD, KennyRA, KorczynA, KosakaK, LeeVM, LeesA, LitvanI, LondosE, LopezOL, MinoshimaS, MizunoY, MolinaJA, Mukaetova-LadinskaEB, PasquierF, PerryRH, SchulzJB, TrojanowskiJQ, YamadaM, Consortium on DLB
(2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology65, 1863–1872.
3.
PetersenRC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med256, 183–194.
4.
LiangYQ, TangXC (2004) Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Neurosci Lett361, 56–59.
5.
QianZM, KeY (2014) Huperzine A: Is it an effective disease-modifying drug for Alzheimer’s disease?. Front Aging Neurosci6, 216.
6.
ZhengW, XiangY-Q, UngvariGS, ChiuFK, NgC, WangY, XiangYT (2016) Huperzine A for treatment of cognitive impairment in major depressive disorder: A systematic review of randomized controlled trials. Shanghai Arch Psychiatry28, 64–71.
7.
LiangY-Q, TangXC (2006) Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats. Acta Pharmacol Sin27, 1127–1136.
8.
YangF, LimGP, BegumAN, UbedaOJ, SimmonsMR, AmbegaokarSS, ChenPP, KayedR, GlabeCG, FrautschySA, ColeGM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem280, 5892–5901.
9.
HuangH-C, TangD, XuK, JiangZ-F (2014) Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway. Transduct Res34, 26–37.
10.
SpinelliKJ, OsterbergVR, MeshulCK, SoumyanathA, Unni1VK (2015) Curcumin treatment improves motor behavior in α-synuclein transgenic mice.PLoS One10, e0128510.
11.
NgQX, KohSSH, ChanHW, HoCYX (2017) Clinical use of curcumin in depression: A meta-analysis. J Am Med Dir Assoc18, 503–508.
12.
TabiraT, KawamuraN, KudohC (2017) A study on a supplement containing curcumin, piperine, squalene, DHA, vitamin E/C/B12/B6, folate, and huperzine A for mild cognitive impairment. Jap Soc Early Stage Dement10, 26–34.
13.
MoréMI, FreitasU, RutenbergD (2014) Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer’s disease and dementia. Adv Ther31, 1247–1262.
14.
OhbaT, YoshinoY, IshisakaM, AbeN, TsurumaK, ShimazawaM, OyamaM, TabiraT, HaraH (2015) Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice. Biosci Biotechnol Biochem79, 1838–1844.
